Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?
about
Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertensionFunctional changes in pulmonary arterial endothelial cells associated with BMPR2 mutationsRole of endothelin-1 in lung diseaseSafety, efficacy, and clinical utility of macitentan in the treatment of pulmonary arterial hypertensionEndothelinVascular endothelial dysfunction and pharmacological treatmentClinical pharmacokinetics and pharmacodynamics of the endothelin receptor antagonist macitentanMolecular mechanisms of pulmonary arterial remodelingMetabolic dysfunction in pulmonary hypertension: the expanding relevance of the Warburg effectCardiomyocyte-specific overexpression of HEXIM1 prevents right ventricular hypertrophy in hypoxia-induced pulmonary hypertension in miceImpact of Superoxide Dismutase Mimetic AEOL 10150 on the Endothelin System of Fischer 344 RatsPulmonary arterial hypertension: the clinical syndrome.Transcriptional down-regulation of the rabbit pulmonary artery endothelin B receptor during phenotypic modulationAdrenomedullin expression and growth inhibitory effects in distinct pulmonary artery smooth muscle cell subpopulations.Endothelins in health and disease: an overview.Endothelin-1 release from cultured endothelial cells induced by sera from patients with systemic lupus erythematosusPrimary pulmonary hypertension in childhood.Hypoxaemia and release of endothelin-1Circulating endothelin in children with congenital heart diseaseRapid increase in plasma endothelin concentrations during percutaneous balloon dilatation of the mitral valve in patients with mitral stenosis.Cell signaling by protein carbonylation and decarbonylation.Kidney dysfunction in patients with pulmonary arterial hypertensionHypoxia-induced mitogenic factor (FIZZ1/RELMα) induces endothelial cell apoptosis and subsequent interleukin-4-dependent pulmonary hypertensionLeptin deficiency recapitulates the histological features of pulmonary arterial hypertension in mice.Pulmonary arterial hypertension in adults: novel drugs and catheter ablation techniques show promise? Systematic review on pharmacotherapy and interventional strategies.Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapiesSaudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Medical and surgical management for pulmonary arterial hypertension.Pulmonary oxidative stress is increased in cyclooxygenase-2 knockdown mice with mild pulmonary hypertension induced by monocrotaline5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension.Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia.Endothelin: what does the radiologist need to know?BMPR2 mutation alters the lung macrophage endothelin-1 cascade in a mouse model and patients with heritable pulmonary artery hypertension.Pulmonary arterial hypertension: new ideas and perspectives.Sitaxsentan therapy for pulmonary arterial hypertension.Pulmonary hypertension in infants with bronchopulmonary dysplasiaInhaled treprostinil and pulmonary arterial hypertension.Integrated care and optimal management of pulmonary arterial hypertensionEndothelin-1 augments Na⁺/H⁺ exchange activity in murine pulmonary arterial smooth muscle cells via Rho kinase.Influence of different degrees of liver impairment on the pharmacokinetics of clazosentan.Management of acute right ventricular failure in the intensive care unit
P2860
Q21284417-C79C7ABC-2663-45DD-9588-876081637B67Q24303490-9697D654-31F3-44E0-8F44-348F7C81ADCCQ24791936-40F51400-34E7-40EE-A3A0-81A3DFE4EC02Q26747812-5DE20747-FA6F-415D-B737-272236CCF483Q26767156-6630397E-895F-410C-9D29-2593141563ACQ26774561-966C4004-E19C-4361-ADED-34A8B395EABFQ26851546-9B4A6DFC-F334-4BBE-B8EA-9CF5300E6803Q26991806-9A84F434-5985-448B-8E02-D46B1E6FD659Q27024293-98570D99-B8D8-4277-A5FF-CB823B480CACQ28484674-1EA792D0-857C-4700-9FE8-268CE08E940AQ28550890-33DC534D-F493-427C-A294-2392F4F3EA90Q30583630-87E08A54-B219-4F7F-B5D2-920E26C4A979Q30650449-6B10CDF5-C333-4FC8-ADFE-FB387A24B136Q31834463-F794D8A9-A1D0-48A7-8EFD-BF68CBDC3419Q33538205-A2B083D8-CA15-40EE-A7B6-3C8AECFEBB93Q33567271-0619FBC1-485A-44DA-A314-8117C037FAB5Q33588070-D014A98D-F121-4137-AC63-EDD76777635CQ33605325-53D79E36-18DF-46A0-92E0-2D3927EB989CQ33612430-33C7B04C-62A9-428B-8556-547E327574D3Q33612615-3E262157-74EC-41C0-9450-2505A4130BB4Q33661117-04A8694C-465A-4604-B38A-F83DF763E250Q33738621-D511F83C-8A28-4BEF-94C6-2013EF3DFAA1Q33764751-1404F7EE-638B-4D3B-94A9-0B4F24032A4DQ33803046-D1E4F1ED-FEFC-45C5-829D-333A8E984368Q33810499-6C0447BB-DDFF-41D0-B474-6241E29E1E5CQ33849207-E5A40972-8B1D-4CF1-BE2B-2D1EA30B173AQ33965898-5C90530B-FD82-41CD-B6D6-243941CBA76EQ33995716-CB4DF6B7-BA8F-4B64-AE17-87D6171D8F57Q34035781-855FF0FB-9207-44D6-A642-FD3FE77B5938Q34110398-730D5901-C29A-4DCD-B3EF-E57C0266540BQ34155501-197B2690-8563-4095-ACA8-1426C69A1427Q34180789-62FBA96B-CBE9-493E-8C43-4788AC43699DQ34184139-22142D58-39C6-435F-BA1A-699AEA0ED608Q34278168-51ECC8D6-41C2-4FE2-BE06-27011C0A20FCQ34363041-700609E1-8E2A-4265-9A84-B59F7AAC704AQ34417507-7ACE448B-1DFC-4EB0-9F0C-F2C540A05816Q34417785-CE8A1187-820D-4909-94D0-3662F76DB017Q34431049-C7A4903D-3645-4A7E-89C6-1ABDB007E093Q34476083-8D546C4C-2060-4A05-8EAC-AE418CD63660Q34479233-C747700E-5FD9-42D8-BE84-EF8DFF73ACDF
P2860
Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?
@en
Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?
@nl
type
label
Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?
@en
Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?
@nl
prefLabel
Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?
@en
Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?
@nl
P2093
P1476
Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?
@en
P2093
P304
P356
10.7326/0003-4819-114-6-464
P407
P577
1991-03-01T00:00:00Z